1993
Needle exchange decreases the prevalence of HIV-1 proviral DNA in returned syringes in New Haven, Connecticut
Heimer R, Kaplan E, Khoshnood K, Jariwala B, Cadman E. Needle exchange decreases the prevalence of HIV-1 proviral DNA in returned syringes in New Haven, Connecticut. The American Journal Of Medicine 1993, 95: 214-220. PMID: 8356986, DOI: 10.1016/0002-9343(93)90263-o.Peer-Reviewed Original ResearchConceptsHIV-1 proviral DNANeedle exchange programsProviral DNANew Haven's needle exchange programNeedle exchangeHIV-1 prevalenceIntravenous drug usersNeedle exchange clientsDrug treatment programsPercentage of syringesDrug use habitsSyringe trackingDNA prevalenceNew HavenPolymerase chain reactionDrug treatmentDrug usersTreatment programPrevalenceChain reactionExchange programsSyringesMonthsProgram participantsFunded evaluationLet the Needles Do the Talking! Evaluating the New Haven Needle Exchange
Kaplan E, O'Keefe E. Let the Needles Do the Talking! Evaluating the New Haven Needle Exchange. Interfaces 1993, 23: 7-26. DOI: 10.1287/inte.23.1.7.Peer-Reviewed Original ResearchHow many drug injectors are there in New Haven? Answers from AIDS data
Kaplan E, Soloshatz D. How many drug injectors are there in New Haven? Answers from AIDS data. Mathematical And Computer Modelling 1993, 17: 109-115. DOI: 10.1016/0895-7177(93)90243-r.Peer-Reviewed Original Research
1992
Needle exchange or needless exchange? The state of the debate.
Kaplan E. Needle exchange or needless exchange? The state of the debate. Infectious Agents And Disease 1992, 1: 92-8. PMID: 1365534.Peer-Reviewed Original ResearchConceptsNeedle exchange programsNeedle exchangeHuman immunodeficiency virus (HIV) infectionImmunodeficiency virus infectionDrug injection equipmentHIV incidenceVirus infectionDrug usersMatter of debateProgram clientsOngoing studiesInjection equipmentFurther investigationExchange programsNew HavenInfectionIncidenceCT
1991
Heterogeneity in patient populations explains differences in in vitro fertilization programs**Presented in part at the 45th and 46th Annual Meetings of the American Fertility Society, San Francisco, California, November 13 to 16, 1989, and Washington, D.C., October 13 to 18, 1990.
Hershlag A, Kaplan E, Loy R, DeCherney A, Lavy G. Heterogeneity in patient populations explains differences in in vitro fertilization programs**Presented in part at the 45th and 46th Annual Meetings of the American Fertility Society, San Francisco, California, November 13 to 16, 1989, and Washington, D.C., October 13 to 18, 1990. Fertility And Sterility 1991, 56: 913-917. PMID: 1936326, DOI: 10.1016/s0015-0282(16)54664-0.Peer-Reviewed Original Research